Cytosorbents (CTSO) Raw Materials (2023 - 2026)

Cytosorbents (CTSO) posted Raw Materials of $552000.0 for Q1 2026, down 26.5% on a QoQ basis from $751000.0 in Q4 2025, and up 0.95% year-over-year from $546805.0 in Q1 2025.

Cytosorbents (CTSO) Raw Materials (2023 - 2026) Analysis & Trends

Cytosorbents' Raw Materials history runs 4 years deep, the most recent figure standing at $552000.0 for Q1 2026.

  • Quarterly Raw Materials rose 0.95% year-over-year to $552000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $552000.0 (up 0.95% YoY) and the FY2025 annual result came in at $751000.0, up 31.75% from the prior year.
  • Raw Materials was $552000.0 for Q1 2026 at Cytosorbents, down from $751000.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $751000.0 in Q4 2025 and bottomed at $491000.0 in Q2 2025.
  • A 4-year average of $594515.1 and a median of $565000.0 in 2025 frame the typical range for Raw Materials.
  • Annual changes were most pronounced in 2024 — Raw Materials declined 16.89% — and 2025, when it jumped 31.75%.
  • Cytosorbents' Raw Materials stood at $685801.0 in 2023, then retreated by 16.89% to $570000.0 in 2024, then surged by 31.75% to $751000.0 in 2025, then retreated by 26.5% to $552000.0 in 2026.
  • Business Quant data shows CTSO's Raw Materials at $552000.0 in Q1 2026, $751000.0 in Q4 2025, and $565000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Cytosorbents 22.58 Mn 17.78 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 552,000.00
Dec 31, 2025 751,000.00
Sep 30, 2025 565,000.00
Jun 30, 2025 491,000.00
Mar 31, 2025 546,805.00
Dec 31, 2024 570,000.00
Dec 31, 2023 685,801.00